The Role of Lipid Rafts in Billirubin Neurotoxicity

脂筏在胆红素神经毒性中的作用

基本信息

项目摘要

 DESCRIPTION (provided by applicant): Bilirubin, the breakdown product of heme, is a known neurotoxicant. In the United States, hyperbilirubinemia occurs in almost all preterm neonates <35 weeks gestation. In preterm infants, it is unknown at what level bilirubin causes neurodevelopmental harm. Bilirubin rises to a level where the unconjugated free bilirubin (Bf) concentration exceeds the plasma's capacity to bind it. Then, Bf crosses the blood brain barrier and binds to its targets including the phospholipids of neurons. Once Bf crosses the blood brain barrier, the clinical syndrome of bilirubin-induced neurologic dysfunction can occur. Acute symptoms include high pitched cry, seizures, and hypo- or hypertonicity, whereas chronic symptoms include disturbed movement and balance. Despite the high prevalence of hyperbilirubinemia, the mechanisms underlying the effects of Bf on neuronal function are poorly understood. The affinity of Bf with neuronal phospholipids suggests that lipid rafts might be a major target in hyperbilirubinemia. Lipid rafts are specialized dynamic microdomains of the plasma membrane containing cholesterol as well as the phospholipid sphingomyelin. They promote protein-protein interactions and facilitate signaling and protein trafficking. For example, lipid rafts play a major role on L1 cell adhesion molecule (L1) mediated neurite outgrowth, a crucial step in cerebellar development that depends on both signal transduction and protein trafficking. Our preliminary results show that bilirubin inhibits lipid raft function using L1 as a reporter. In addition, our prior work shows that lipid raft dysfunction can be reduced with supplementation of choline, a precursor of phosphatidylcholine and sphingomyelin. Our novel hypotheses are that 1) free unconjugated bilirubin binds to and causes lipid raft dysfunction, resulting in cerebellar dysfunction; and 2) supplementation with choline will reduce these effects. We will address these hypotheses using both the well established model of cultured cerebellar granule neurons from postnatal day 6 heterozygous Gunn rat pups and the sulfadimethoxine treated homozygous Gunn rat as an in vivo rat pup model. We will use L1, the GABAA receptor, β III tubulin, flotilin and caveolin as reporter proteins to test lipid raft functon in cerebellar granule neurons (CGN) in vitro and in Gunn rat pups in vivo, determine cerebellar weight and test behavioral outcomes: both the constant and accelerating rotarod test. We will test our hypotheses using two specific aims: The first aim will determine if bilirubin accumulates within lipid rafts and its effects on functions of lipid rafts and apoptosis. The effect of choline supplementation on these effects of bilirubin will be determined. In the second aim, the effect of bilirubin on cerebellar weight and cerebellar function will be measured, and the effect of pretreatment with choline determined.
 描述(由申请人提供):胆红素是血红素的分解产物,是一种已知的神经毒物。在美国,几乎所有妊娠<35周的早产儿都会出现高胆红素血症。在早产儿中,尚不清楚胆红素达到什么水平会导致神经发育损害。胆红素升高到未结合的游离胆红素 (Bf) 浓度超过血浆结合胆红素的能力的水平。然后,Bf 穿过血脑屏障并与其目标结合,包括神经元的磷脂。 Bf一旦穿过血脑屏障,就会出现胆红素引起的神经功能障碍的临床综合征。急性症状包括高声哭泣、癫痫发作、肌张力低下或肌张力过高,而慢性症状包括运动和平衡障碍。尽管高胆红素血症的患病率很高,但 Bf 对神经元功能影响的机制尚不清楚。 Bf 与神经元磷脂的亲和力表明脂筏可能是高胆红素血症的主要目标。脂筏是质膜的专门动态微域,含有胆固醇和磷脂鞘磷脂。它们促进蛋白质-蛋白质相互作用并促进信号传导和蛋白质运输。例如, 脂筏在 L1 细胞粘附分子 (L1) 介导的神经突生长中发挥重要作用,这是小脑发育中的关键步骤,依赖于信号转导和蛋白质运输。我们的初步结果表明胆红素利用 L1 作为抑制脂筏功能 记者。此外,我们之前的工作表明,补充胆碱(磷脂酰胆碱和鞘磷脂的前体)可以减少脂筏功能障碍。我们的新假设是:1)游离非结合胆红素结合并引起脂筏功能障碍,导致小脑功能障碍; 2)补充胆碱会减少这些影响。我们将使用来自出生后第 6 天的杂合 Gunn 大鼠幼崽的已建立的小脑颗粒神经元培养模型和磺胺二甲氧嘧啶处理的纯合 Gunn 大鼠作为体内大鼠幼崽模型来解决这些假设。我们将使用 L1、GABAA 受体、β III 微管蛋白、flotilin 和 Caveolin 作为报告蛋白,在体外测试小脑颗粒神经元 (CGN) 和体内 Gunn 幼鼠的脂筏功能,确定小脑重量并测试行为结果:恒定和加速旋转测试。我们将使用两个具体目标来检验我们的假设:第一个目标将确定胆红素是否在脂筏内积聚及其对脂筏功能和细胞凋亡的影响。胆碱的作用 将确定补充胆红素对这些作用的影响。第二个目标是测量胆红素对小脑重量和小脑功能的影响,并确定胆碱预处理的效果。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CYNTHIA FRANCES BEARER其他文献

CYNTHIA FRANCES BEARER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CYNTHIA FRANCES BEARER', 18)}}的其他基金

Mechanism of Bilirubin-induced Apnea in Preterm Infants
胆红素诱发早产儿呼吸暂停的机制
  • 批准号:
    10494280
  • 财政年份:
    2021
  • 资助金额:
    $ 23.26万
  • 项目类别:
Mechanism of Bilirubin-induced Apnea in Preterm Infants
胆红素诱发早产儿呼吸暂停的机制
  • 批准号:
    10373330
  • 财政年份:
    2021
  • 资助金额:
    $ 23.26万
  • 项目类别:
Effects of Perinatal Hypoxia-Ischemia on the Developing Cerebellum With and Without Prior Inflammation
围产期缺氧缺血对有或没有炎症的小脑发育的影响
  • 批准号:
    9151504
  • 财政年份:
    2016
  • 资助金额:
    $ 23.26万
  • 项目类别:
Project III- Impact of Hypoxia-Ischemia and/or Inflammation on Lipid Rafts in Cerebellum
项目 III- 缺氧缺血和/或炎症对小脑脂筏的影响
  • 批准号:
    9979924
  • 财政年份:
    2016
  • 资助金额:
    $ 23.26万
  • 项目类别:
The Role of Lipid Rafts in Billirubin Neurotoxicity
脂筏在胆红素神经毒性中的作用
  • 批准号:
    9244807
  • 财政年份:
    2016
  • 资助金额:
    $ 23.26万
  • 项目类别:
Effects of Perinatal Hypoxia-Ischemia on the Developing Cerebellum With and Without Prior Inflammation
围产期缺氧缺血对有或没有炎症的小脑发育的影响
  • 批准号:
    9979910
  • 财政年份:
    2016
  • 资助金额:
    $ 23.26万
  • 项目类别:
The Role of Lipid Rafts in Fetal Alcohol Spectrum Disorder
脂筏在胎儿酒精谱系障碍中的作用
  • 批准号:
    8066801
  • 财政年份:
    2007
  • 资助金额:
    $ 23.26万
  • 项目类别:
The Role of Lipid Rafts in Fetal Alcohol Spectrum Disorder
脂筏在胎儿酒精谱系障碍中的作用
  • 批准号:
    7881454
  • 财政年份:
    2007
  • 资助金额:
    $ 23.26万
  • 项目类别:
The Role of Lipid Rafts in Fetal Alcohol Spectrum Disorder
脂筏在胎儿酒精谱系障碍中的作用
  • 批准号:
    7267884
  • 财政年份:
    2007
  • 资助金额:
    $ 23.26万
  • 项目类别:
The Role of Lipid Rafts in Fetal Alcohol Spectrum Disorder
脂筏在胎儿酒精谱系障碍中的作用
  • 批准号:
    7414075
  • 财政年份:
    2007
  • 资助金额:
    $ 23.26万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.26万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 23.26万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.26万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.26万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 23.26万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.26万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.26万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.26万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 23.26万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 23.26万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了